van Meir, H., du Burck, I. J., de Kam, M. L., Welters, M. J. P., van der Burg, S. H., Trimbos, J. B. M. Z., . . . van Poelgeest, M. I. E. (2017). The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer. European Journal of Gynaecological Oncology, 38(1), 25. https://doi.org/10.12892/ejgo3628.2017
Chicago Style (17th ed.) Citationvan Meir, H., I. J. du Burck, M. L. de Kam, M. J. P. Welters, S. H. van der Burg, J. B. M. Z. Trimbos, C. D. de Kroon, and M. I. E. van Poelgeest. "The Identification of Patients at High Risk for Recurrent Disease After Treatment for Early-stage Cervical Cancer." European Journal of Gynaecological Oncology 38, no. 1 (2017): 25. https://doi.org/10.12892/ejgo3628.2017.
MLA (9th ed.) Citationvan Meir, H., et al. "The Identification of Patients at High Risk for Recurrent Disease After Treatment for Early-stage Cervical Cancer." European Journal of Gynaecological Oncology, vol. 38, no. 1, 2017, p. 25, https://doi.org/10.12892/ejgo3628.2017.